Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2412]

New screening approach identified potential drug combinations for difficult-to-treat forms of melanoma

New screening approach identified potential drug combinations for difficult-to-treat forms of melanoma

'Significant' new cancer drug resistance mechanism identified

'Significant' new cancer drug resistance mechanism identified

FDA approves use of abiraterone acetate for metastatic castration-resistant prostate cancer

FDA approves use of abiraterone acetate for metastatic castration-resistant prostate cancer

Positive early results in clinical trial for DNA vaccine

Positive early results in clinical trial for DNA vaccine

ASH 2012: Genetic susceptibility to anthracycline-related heart failure identified in survivors of haematopoietic cell transplantation

ASH 2012: Genetic susceptibility to anthracycline-related heart failure identified in survivors of haematopoietic...

SABCS 2012: Cognitive problems may be present before chemotherapy in women with breast cancer

SABCS 2012: Cognitive problems may be present before chemotherapy in women with breast cancer

$SABCS 2012: Hypofractionated radiotherapy was safe, effective for early breast cancer treatment at 10-year follow-up$

SABCS 2012: Hypofractionated radiotherapy was safe, effective for early breast cancer treatment at 10-year follow...

SABCS 2012: HDAC inhibitors sensitised triple-negative breast cancer cells to PARP inhibition and cisplatin treatment

SABCS 2012: HDAC inhibitors sensitised triple-negative breast cancer cells to PARP inhibition and cisplatin...

SABCS 2012: Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemotherapy

SABCS 2012: Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemotherapy

SABCS 2012: Young women with breast cancer were more likely than older women to respond to neoadjuvant chemotherapy

SABCS 2012: Young women with breast cancer were more likely than older women to respond to neoadjuvant chemotherapy

More from ecancer